Jennifer Amidi
Papers
1
Total Citations
6
H-Index
1
About
Jennifer Amidi’s research centers on advancing diagnostic accuracy in prostate cancer, particularly through the application of molecular imaging. Her most cited work, a 2021 retrospective study, rigorously evaluated the accuracy of [18F]-fluorocholine PET/CT for primary staging of lymph node metastases in intermediate and high-risk prostate cancer patients undergoing robotic-assisted laparoscopic prostatectomy with extended lymph node dissection. This study directly addressed a critical clinical gap, challenging the prevailing view that FCH PET/CT is not recommended for primary staging by providing nuanced data on its performance. With 6 citations, this paper has already informed oncologists and radiologists seeking to optimize preoperative planning. Amidi’s contribution lies in her meticulous methodology—comparing PET/CT findings against the gold standard of histopathology from extended lymph node dissection—offering a clearer picture of where this imaging modality holds value. Her work underscores a commitment to evidence-based refinement of staging protocols, ultimately aiming to reduce unnecessary surgeries and improve patient outcomes. As a researcher, Amidi exemplifies the rigorous, clinically anchored investigation needed to translate emerging imaging technologies into practical oncology guidelines.
Research Focus
Key Achievements
Top Papers
- 1